Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Introducing neoadjuvant chemotherapy (NCT) in a breast cancer patient may be associated with changes in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth hormone receptor 2 (HER2) status.

Bibliographic Details
Main Authors: Taha Heba F., Elfarargy Ola M., Salem Reham A., Mandour Doaa, Salem Amira A., Riad Mohamed
Format: Article
Language:English
Published: Sciendo 2021-05-01
Series:Forum of Clinical Oncology
Subjects:
breast cancer
neoadjuvant chemotherapy
concordance between er
pr
her2 neu
prognosis
Online Access:https://doi.org/10.2478/fco-2019-0021

Internet

https://doi.org/10.2478/fco-2019-0021

Similar Items